Access the full text.
Sign up today, get DeepDyve free for 14 days.
F. Verburg, T. Krohn, A. Heinzel, F. Mottaghy, F. Behrendt (2015)
First evidence of PSMA expression in differentiated thyroid cancer using [68Ga]PSMA-HBED-CC PET/CTEuropean Journal of Nuclear Medicine and Molecular Imaging, 42
K. Bouchelouche, B. Turkbey, P. Choyke, J. Capala (2010)
Imaging Prostate Cancer: An Update on Positron Emission Tomography and Magnetic Resonance ImagingCurrent Urology Reports, 11
N. Schülke, O. Varlamova, G. Donovan, D. Ma, J. Gardner, D. Morrissey, Robert Arrigale, C. Zhan, A. Chodera, K. Surowitz, P. Maddon, W. Heston, W. Olson (2003)
The homodimer of prostate-specific membrane antigen is a functional target for cancer therapyProceedings of the National Academy of Sciences of the United States of America, 100
T. Krohn, F. Verburg, T. Pufe, W. Neuhuber, A. Vogg, A. Heinzel, F. Mottaghy, F. Behrendt (2015)
[68Ga]PSMA-HBED uptake mimicking lymph node metastasis in coeliac ganglia: an important pitfall in clinical practiceEuropean Journal of Nuclear Medicine and Molecular Imaging, 42
M. Eder, O. Neels, Miriam Müller, U. Bauder-Wüst, Yvonne Remde, M. Schäfer, Ute Hennrich, M. Eisenhut, A. Afshar-Oromieh, U. Haberkorn, K. Kopka (2014)
Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate CancerPharmaceuticals, 7
D. Hellwig, J. Moosbauer, C. Eilles (2014)
Ga-68-PSMA-PET/CT bei ProstatakarzinomAktuelle Urologie, 45
R. Brindle, D. Mullan, B. Yap, A. Gandhi (2014)
Thyroid incidentalomas discovered on positron emission tomography CT scanning - Malignancy rate and significance of standardised uptake values.European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 40 11
E. Demirci, M. Ocak, L. Kabasakal, C. Decristoforo, Z. Talat, M. Halaç, B. Kanmaz (2014)
68Ga-PSMA PET/CT imaging of metastatic clear cell renal cell carcinomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 41
A. Afshar-Oromieh, A. Malcher, M. Eder, M. Eisenhut, H. Linhart, B. Hadaschik, T. Holland-Letz, F. Giesel, C. Kratochwil, S. Haufe, U. Haberkorn, C. Zechmann (2013)
PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesionsEuropean Journal of Nuclear Medicine and Molecular Imaging, 40
M. Schäfer, U. Bauder-Wüst, K. Leotta, F. Zoller, W. Mier, U. Haberkorn, M. Eisenhut, M. Eder (2012)
A dimerized urea-based inhibitor of the prostate-specific membrane antigen for 68Ga-PET imaging of prostate cancerEJNMMI Research, 2
P. Chakraborty, M. Tripathi, K. Agarwal, R. Kumar, M. Vijay, C. Bal (2015)
Metastatic poorly differentiated prostatic carcinoma with neuroendocrine differentiation: negative on 68Ga-PSMA PET/CT.Clinical nuclear medicine, 40 2
A. Afshar-Oromieh, U. Haberkorn, M. Eder, M. Eisenhut, C. Zechmann (2012)
[68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECHEuropean Journal of Nuclear Medicine and Molecular Imaging, 39
Sam Chang, V. Reuter, W. Heston, N. Bander, L. Grauer, P. Gaudin (1999)
Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature.Cancer research, 59 13
D Hellwig, J Moosbauer, C Eilles (2014)
68Ga-PSMA PET/CT for prostate cancerAktuelle Urol, 45
G. Hruby, T. Eade, L. Emmett, B. Ho, E. Hsiao, G. Schembri, Linxin Guo, C. Kwong, J. Hunter, K. Byrne, A. Kneebone (2018)
68Ga‐PSMA‐PET/CT staging prior to definitive radiation treatment for prostate cancerAsia‐Pacific Journal of Clinical Oncology, 14
N. Dubrawsky (1989)
Cancer statisticsCA: A Cancer Journal for Clinicians, 39
R. Siegel, Jiemin Ma, Zhaohui Zou, A. Jemal (2014)
Cancer statistics, 2014CA: A Cancer Journal for Clinicians, 64
David Silver, Inmaculada Pellicer, W. Fair, W. Heston, C. Cordon-Cardo (1997)
Prostate-specific membrane antigen expression in normal and malignant human tissues.Clinical cancer research : an official journal of the American Association for Cancer Research, 3 1
68Ga-Prostate specific membrane antigen- N,N′-bis[2-hydroxy-5-(carboxyethyl)benzyl]ethylenediamine-N,N′-diacetic acid- positron emission tomography/computed tomography or 68 Ga- HBED-CC-PSMA PET/CT, popularly known as PSMA PET/CT, is able to detect a small volume of recurrent prostate carcinoma (PC) when there is a prostate specific antigen (PSA) rise on follow-up after prostatectomy or other definitive treatment for PC. The use of PSMA PET/CT in the initial staging in PC is uncertain at this time. Clinical studies are underway to define its exact role in the management of the disease. At the same time it is important to be aware of unexpected sites of uptake of this ligand. We present here the case of a 62-year-old male patient who underwent prostatectomy for adenocarcinoma prostate. He also had a long-standing left solitary thyroid nodule (STN). Four months after surgery, he had a rising trend in serum PSA levels on three occasions, but the absolute value was less than 4 at all times. He underwent a 68Ga-PSMA-HBED-CC PET/CT, but it did not reveal any recurrent/metastatic site of disease. However, there was increased tracer uptake in the left STN. Fine needle aspiration cytology revealed features of atypia of undetermined significance, Bethesda category III. The patient underwent a left hemithyroidectomy and the histopathology showed features of a follicular adenoma.
Nuclear Medicine and Molecular Imaging – Springer Journals
Published: Mar 22, 2016
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.